CVS bid for Aetna: A $66 billion bet on cutting drug costs | | NEW YORK (Reuters) - The proposed merger between U.S. pharmacy operator CVS Health Corp and No. 3 health insurer Aetna Inc represents a $66 billion bet that insurers can drive down high U.S. drug prices by cutting out the middleman. |
| |
Merck Keytruda sales soar, but European application pulled | | (Reuters) - Merck & Co on Friday said quarterly sales of its Keytruda cancer immunotherapy exceeded $1 billion for the first time, but it withdrew an application for European use of the drug in lung cancer, raising questions about future sales. |
| |
CVS makes more than $66 billion bid for Aetna: sources | | (Reuters) - U.S. pharmacy operator CVS Health Corp has made an offer to acquire No. 3 U.S. health insurer Aetna Inc for more than $200 per share, or over $66 billion, people familiar with the matter said on Thursday. |
| |
McDonald's sets new welfare standards for chickens | | CHICAGO (Reuters) - McDonald's Corp will require suppliers to follow new standards for raising and slaughtering chickens served in its restaurants, the company said on Friday, the latest changes affecting popular menu items like McNuggets. |
| |
| | |